A dynamic COVID-19 immune signature includes associations with poor prognosis

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884

Clinical characteristics of coronavirus disease 2019 in China

Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969

Dexamethasone in Hospitalized Patients with Covid-19

The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477

Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

Horby, P., Lim, W. S., Emberson, J., Mafham, M., Bell, J., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., Elmahi, E., et al. (2020) · doi:10.1101/2020.06.22.20137273 · Cited by 11,475

COVID-19: consider cytokine storm syndromes and immunosuppression

Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664

Virological assessment of hospitalized patients with COVID-2019

Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661

SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients

Zou, L., Ruan, F., Huang, M.-X., Liang, L.-J., Huang, H., Hong, Z.-S., Yu, J.-X., Kang, M., Song, Y.-C., Xia, J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001737 · Cited by 4,590

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405

Increased IL-8, Neutrophil Activation Phenotypes and NETosis in Critically Ill COVID-19 Patients

Masso-Silva, J. A., Moshensky, A., Lam, M. T. Y., Odish, M. F., Patel, A., Xu, L., Hansen, E. A., Trescott, S., Nguyen, C. T., Kim, R. Y., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciab437 · Cited by 128

Cardiometabolic Traits, Sepsis, and Severe COVID-19

Ponsford, M., Gkatzionis, A., Walker, V. M., Grant, A. J., Wootton, R. E., Moore, L. S. P., Fatumo, S., Mason, A. M., Zuber, V., Willer, C. J., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.050753 · Cited by 124

Biological Phenotyping in Sepsis and Acute Respiratory Distress Syndrome

Sinha, P., Meyer, N. J., & Calfee, C. S. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-043021-014005 · Cited by 128

Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection

Pérez‐Gómez, A., Vitallé, J., Gasca‐Capote, C., Gutiérrez‐Valencia, A., Trujillo‐Rodríguez, M., Serna‐Gallego, A., Muñoz‐Muela, E., Jiménez‐León, M. R., Benhnia, M. R., Rivas‐Jeremías, I., et al. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00728-2 · Cited by 121

The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients

Perreau, M., Suffiotti, M., Marques-Vidal, P. M., Wiedemann, A., Lévy, Y., Laouenan, C., Ghosn, J., Fenwick, C. W., Comte, D., Roger, T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25191-5 · Cited by 123

Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19

Kaiser, R. W. J., Leunig, A., Pekayvaz, K., Popp, O., Joppich, M., Polewka, V., Escaig, R., Anjum, A., Hoffknecht, M., Gold, C., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.150862 · Cited by 125

Innate immunity, cytokine storm, and inflammatory cell death in COVID-19

Karki, R., & Kanneganti, T. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03767-z · Cited by 131

Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity

Mengist, H. M., Kombe, A. J. K., Mekonnen, D. S., Abebaw, A., Getachew, M., & Jin, T. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101533 · Cited by 115

Single-cell immunology of SARS-CoV-2 infection

Tian, Y., Carpp, L. N., Miller, H. E. R., Zager, M. A., Newell, E. W., & Gottardo, R. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-01131-y · Cited by 114

SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic

Bertoletti, A., Bert, N. L., & Tan, A. T. (2022) · Immunity · doi:10.1016/j.immuni.2022.08.008 · Cited by 118

Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context

Angriman, F., Ferreyro, B. L., Burry, L. D., Fan, E., Ferguson, N. D., Husain, S., Keshavjee, S. H., Lupia, E., Munshi, L., Renzi, S., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00139-9 · Cited by 119

The legacy of maternal SARS-CoV-2 infection on the immunology of the neonate

Gee, S., Chandiramani, M., Seow, J., Pollock, E., Modestini, C., Das, A., Tree, T. I. M., Doores, K. J., Tribe, R. M., & Gibbons, D. L. (2021) · Nature Immunology · doi:10.1038/s41590-021-01049-2 · Cited by 117

Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients

Abdul-Jawad, S., Baù, L., Alaguthurai, T., del Barrio, I. D. M., Laing, A. G., Hayday, T. S., Monin, L., Muñoz‐Ruiz, M., McDonald, L., Francos-Quijorna, I., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.01.001 · Cited by 111

Immunological memory to SARS-CoV-2 assessed for up to eight months after infection.

Dan, J. M., Mateus, J., Kato, Y., Hastie, K. M., Yu, E. D., Faliti, C. E., Grifoni, A., Ramirez, S. I., Haupt, S., Frazier, A., et al. (2020) · eScholarship (California Digital Library) · Cited by 121

SARS-CoV-2 variants evolve convergent strategies to remodel the host response

Bouhaddou, M., Reuschl, A., Polacco, B. J., Thorne, L., Ummadi, M. R., Ye, C., Rosales, R., Pelin, A., Batra, J., Jang, G. Μ., et al. (2023) · Cell · doi:10.1016/j.cell.2023.08.026 · Cited by 120

The immunology of SARS-CoV-2 infections and vaccines

Grigoryan, L., & Pulendran, B. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101422 · Cited by 102

Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19

Peter, A. E., Sandeep, B. V., Rao, B. G., & Kalpana, V. L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.583777 · Cited by 106

Lessons learned: new insights on the role of cytokines in COVID-19

Buszko, M., Nita‐Lazar, A., Park, J., Schwartzberg, P. L., Verthelyi, D. I., Young, H. A., & Rosenberg, A. S. (2021) · Nature Immunology · doi:10.1038/s41590-021-00901-9 · Cited by 99

Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19

Britton, G. J., Chen-Liaw, A., Cossarini, F., Livanos, A. E., Spindler, M. P., Plitt, T., Eggers, J., Mogno, I., Gonzalez-Reiche, A. S., Siu, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-92740-9 · Cited by 99

The cytokine storm and thyroid hormone changes in COVID-19

Croce, L., Gangemi, D., Ancona, G., Liboà, F., Bendotti, G., Minelli, L., & Chiovato, L. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01506-7 · Cited by 103

COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine

Pereira, N. L., Ahmad, F., Byku, M., Cummins, N. W., Morris, A. A., OWENS, A. T., Tuteja, S., & Cresci, S. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.11.024 · Cited by 93

Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant

Thorne, L. G., Bouhaddou, M., Reuschl, A.-K., Zuliani-Alvarez, L., Polacco, B., Pelin, A., Batra, J., Whelan, M. V. X., Ummadi, M., Rojc, A., et al. (2021) · doi:10.1101/2021.06.06.446826 · Cited by 91

Impaired function and delayed regeneration of dendritic cells in COVID-19

Winheim, E., Rinke, L., Lutz, K., Reischer, A., Leutbecher, A., Wolfram, L., Rausch, L., Kranich, J., Wratil, P. R., Huber, J. E., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009742 · Cited by 89

A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19

Ray, Y., Paul, S. R., Bandopadhyay, P., D’Rozario, R., Sarif, J., Raychaudhuri, D., Bhowmik, D., Lahiri, A., Vasudevan, J. S., Maurya, R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28064-7 · Cited by 92

Saliva viral load is a dynamic unifying correlate of COVID-19 severity and mortalityPreprint

Silva, J. D. S., Lucas, C. G. D. O., Sundaram, M. E., Israelow, B., Wong, P., Klein, J., Tokuyama, M., Lu, P., Venkataraman, A., Liu, F., et al. (2021) · medRxiv · doi:10.1101/2021.01.04.21249236 · Cited by 90

The success of SARS-CoV-2 vaccines and challenges ahead

Subbarao, K. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.06.016 · Cited by 92

Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19

Jørgensen, M. J., Holter, J. C., Christensen, E. E., Schjalm, C., Tonby, K., Pischke, S. E., Jenum, S., Skeie, L. G., Nur, S., Lind, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-78710-7 · Cited by 89

COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes

Jenner, A. L., Aogo, R. A., Alfonso, S., Crowe, V., Deng, X., Smith, A. P., Morel, P. A., Davis, C. L., Smith, A. M., & Craig, M. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009753 · Cited by 91

COVID-19: Inflammatory Profile

Wang, Y., & Perlman, S. M. (2021) · Annual Review of Medicine · doi:10.1146/annurev-med-042220-012417 · Cited by 93

High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19

Lourda, M., Dzidic, M., Hertwig, L., Bergsten, H., Medina, L. M. P., Sinha, I., Kvedaraite, E., Chen, P., Muvva, J. R., Gorin, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2109123118 · Cited by 91

COVID-19 and iron dysregulation: distant sequence similarity between hepcidin and the novel coronavirus spike glycoprotein

Ehsani, S. (2020) · Biology Direct · doi:10.1186/s13062-020-00275-2 · Cited by 89

Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview

Khosroshahi, L. M., Rokni, M., Mokhtari, T., & Noorbakhsh, F. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107364 · Cited by 90

Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19

Haljasmägi, L., Salumets, A., Rumm, A. P., Jürgenson, M., Krassohhina, E., Remm, A., Sein, H., Kareinen, L., Vapalahti, O., Sironen, T. A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-77525-w · Cited by 86

Cytokines and Chemokines in SARS-CoV-2 Infections—Therapeutic Strategies Targeting Cytokine Storm

Pum, A., Ennemoser, M., Adage, T., & Kungl, A. J. (2021) · Biomolecules · doi:10.3390/biom11010091 · Cited by 89

Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection

Severa, M., Diotti, R. A., Etna, M. P., Rizzo, F., Fiore, S., Ricci, D., Iannetta, M., Sinigaglia, A., Lodi, A., Mancini, N., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009878 · Cited by 86

COVID-19 disease and immune dysregulation

Davitt, E., Davitt, C., Mazer, M. B., Areti, S. S., Hotchkiss, R. S., & Remy, K. E. (2022) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2022.101401 · Cited by 84

Human marginal zone B cell development from early T2 progenitors

Tull, T. J., Pitcher, M. J., Guesdon, W., Siu, J. H. Y., Lebrero‐Fernández, C., Zhao, Y., Petrov, N., Heck, S., Ellis, R., Dhami, P., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20202001 · Cited by 82

Nature and Dimensions of Systemic Hyperinflammation and its Attenuation by Convalescent Plasma in Severe COVID-19

Bandopadhyay, P., D’Rozario, R., Lahiri, A., Sarif, J., Ray, Y., Paul, S. R., Roy, R., Maiti, R., Chaudhuri, K., Bagchi, S., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab010 · Cited by 83

Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression

Rendeiro, A. F., Casano, J., Vorkas, C. K., Singh, H. K., Morales, A. E., Desimone, R. A., Ellsworth, G. B., Soave, R., Kapadia, S. N., Saito, K., et al. (2020) · Life Science Alliance · doi:10.26508/lsa.202000955 · Cited by 83

Basophils and Mast Cells in COVID-19 Pathogenesis

Murdaca, G., Gioacchino, M. D., Greco, M., Borro, M., Paladin, F., Petrarca, C., & Gangemi, S. (2021) · Cells · doi:10.3390/cells10102754 · Cited by 83

Multiscale PHATE identifies multimodal signatures of COVID-19

Kuchroo, M., Huang, J., Wong, P., Grenier, J.-C., Shung, D., Tong, A., Lucas, C., Klein, J., Burkhardt, D. B., Gigante, S., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-021-01186-x · Cited by 72

Hematopoietic responses to SARS-CoV-2 infection

Elahi, S. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04220-6 · Cited by 79

T cell immunity to SARS-CoV-2

Niessl, J., Sekine, T., & Buggert, M. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101505 · Cited by 77

Pathophysiological mechanisms of thrombosis in acute and long COVID-19

Jing, H., Wu, X., Xiang, M., Liu, L., Novakovic, V. A., & Shi, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.992384 · Cited by 81

Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks

Ruhl, L., Pink, I., Kühne, J. F., Beushausen, K., Keil, J., Christoph, S., Sauer, A., Boblitz, L., Schmidt, J. J., David, S., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00819-6 · Cited by 81

White Blood Cells and Severe COVID-19: A Mendelian Randomization Study

Sun, Y., Zhou, J., & Ye, K. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11030195 · Cited by 73

COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes

MacDonald, L., Alivernini, S., Tolusso, B., Elmesmari, A., Somma, D., Perniola, S., Paglionico, A., Petricca, L., Bosello, S. L., Carfì, A., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.147413 · Cited by 72

SARS-CoV-2 uses CD4 to infect T helper lymphocytes

Brunetti, N. S., Davanzo, G. G., de Moraes, D., Ferrari, A., de Souza, G. F., Muraro, S. P., Knittel, T. L., Boldrini, V. D. O., Monteiro, L. D. B., Virgílio-da-Silva, J. V., et al. (2023) · eLife · doi:10.7554/elife.84790 · Cited by 78

Therapeutic application of estrogen for COVID-19: Attenuation of SARS-CoV-2 spike protein and IL-6 stimulated, ACE2-dependent NOX2 activation, ROS production and MCP-1 upregulation in endothelial cells

Youn, J. Y., Zhang, Y., Wu, Y., Cannesson, M. P., & Cai, H. “. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102099 · Cited by 71

Monocyte HLA‐DR Measurement by Flow Cytometry in COVID ‐19 Patients: An Interim Review

Benlyamani, I., Venet, F., Coudereau, R., Gossez, M., & Monneret, G. (2020) · Cytometry Part A · doi:10.1002/cyto.a.24249 · Cited by 75

Cytokine signature and COVID-19 prediction models in the two waves of pandemics

Cabaro, S., D’Esposito, V., Matola, T. D., Sale, S., Cennamo, M., Terracciano, D., Parisi, V., Oriente, F., Portella, G., Bèguinot, F., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-00190-0 · Cited by 71

Plasma proteome of Long-COVID patients indicates HIF-mediated vasculo-proliferative disease with impact on brain and heart function

Iosef, C., Knauer, M. J., Nicholson, M., Nynatten, L. R. V., Cepinskas, G., Drăghici, S., Han, V. K. M., & Fraser, D. D. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04149-9 · Cited by 70

Pregnancy as a risk factor for severe coronavirus disease 2019 using standardized clinical criteria

Oakes, M. C., Kernberg, A. S., Carter, E. B., Foeller, M. E., Palanisamy, A., Raghuraman, N., & Kelly, J. C. (2021) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2021.100319 · Cited by 213

CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study

Lorè, N. I., LORENZO, R. D., Rancoita, P. M. V., Cugnata, F., Agresti, A., Benedetti, F., Bianchi, M. E., Bonini, C., Capobianco, A., Conte, C., et al. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00390-4 · Cited by 65

Machine learning approaches in Covid-19 severity risk prediction in Morocco

Laatifi, M., Douzi, S., Bouklouz, A., Ezzine, H., Jaafari, J., Zaid, Y., Ouahidi, B. E., & Naciri, M. (2022) · Journal Of Big Data · doi:10.1186/s40537-021-00557-0 · Cited by 68

Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19

Li, X., Zhang, Z., Wang, Z., Gutiérrez-Castrellón, P., & Shi, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01043-6 · Cited by 67

Bacillus Calmette-Guérin–induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 mice

Zhang, B., Shuai, H., Gong, H., Hu, J., Yan, B., Yuen, T. T., Hu, Y., Yoon, C., Wang, X., Hou, Y., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.157393 · Cited by 67

Cytokine Storm Signature in Patients with Moderate and Severe COVID-19

Kalinina, O., Головкин, А. С., Zaikova, E. K., Aquino, A. D., Bezrukikh, V. A., Melnik, O., Vasilieva, E. Y., Каронова, Т. Л., Kudryavtsev, I. V., & Shlyakhto, E. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168879 · Cited by 69

Effect of IL-6, IL-8/CXCL8, IP-10/CXCL 10 levels on the severity in COVID 19 infection

Kesmez Can, F., Özkurt, Z., Öztürk, N., & Sezen, S. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14970 · Cited by 66

T-cell dysregulation in COVID-19

Kalfaoglu, B., Almeida‐Santos, J., Tye, C. A., Satou, Y., & Ono, M. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.10.079 · Cited by 65

The distinct MHC‐unrestricted immunobiology of innate‐like and adaptive‐like human γδ T cell subsets—Nature's CAR‐T cells

Willcox, C. R., Mohammed, F., & Willcox, B. E. (2020) · Immunological Reviews · doi:10.1111/imr.12928 · Cited by 68

Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review)

Vivarelli, S., Falzone, L., Torino, F., Scandurra, G., Russo, G. L., Bordonaro, R., Pappalardo, F., Spandidos, D. A., Raciti, G., & Libra, M. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5159 · Cited by 64

A proteomic survival predictor for COVID-19 patients in intensive care

Demichev, V., Tober‐Lau, P., Nazarenko, T., Aulakh, S. K., Whitwell, H., Lemke, O., Röhl, A., Freiwald, A., Mittermaier, M., Szyrwiel, Ł., et al. (2022) · PLOS Digital Health · doi:10.1371/journal.pdig.0000007 · Cited by 64

Covid‐19 and Liver Injury: Role of Inflammatory Endotheliopathy, Platelet Dysfunction, and Thrombosis

McConnell, M. J., Kondo, R., Kawaguchi, N., & Iwakiri, Y. (2021) · Hepatology Communications · doi:10.1002/hep4.1843 · Cited by 68

Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions

Han, Y., Yuan, K., Wang, Z., Liu, W., Lu, Z.-A., Liu, L., Shi, L., Yan, W., Yuan, J., Li, J., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01629-8 · Cited by 67

Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion

Mazzoni, A., Salvati, L., Maggi, L., Annunziato, F., & Cosmi, L. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101508 · Cited by 69

Diagnosis and prediction of COVID-19 severity: can biochemical tests and machine learning be used as prognostic indicators?

Cobre, A. D. F., Stremel, D. P., Noleto, G. R., Fachi, M. M., Surek, M., Wiens, A., Tonin, F. S., & Pontarolo, R. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104531 · Cited by 63

Role of Basophils in a Broad Spectrum of Disorders

Miyake, K., Ito, J., & Karasuyama, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.902494 · Cited by 65

Syrian hamsters as a model of lung injury with SARS-CoV-2 infection: Pathologic, physiologic, and detailed molecular profiling

Bednash, J. S., Kagan, V. E., Englert, J. A., Farkas, D., Tyurina, Y. Y., Tyurin, V. A., Самович, С. Н., Farkas, L., Elhance, A., Johns, F., et al. (2021) · Translational research · doi:10.1016/j.trsl.2021.10.007 · Cited by 59

Potential SARS-CoV-2 Immune Correlates of Protection in Infection and Vaccine Immunization

Sui, Y., Bekele, Y., & Berzofsky, J. A. (2021) · Pathogens · doi:10.3390/pathogens10020138 · Cited by 57

Sphingolipids as Modulators of SARS-CoV-2 Infection

Törnquist, K., Asghar, M. Y., Srinivasan, V., Korhonen, L., & Lindholm, D. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.689854 · Cited by 60

Stratification of hospitalized COVID-19 patients into clinical severity progression groups by immuno-phenotyping and machine learning

Mueller, Y. M., Schrama, T. J., Ruijten, R., Schreurs, M. W. J., Grashof, D. G. B., van de Werken, H. J. G., Lasinio, G. J., Álvarez‐Sierra, D., Kiernan, C. H., Eiro, M. D. C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28621-0 · Cited by 58

Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches

Hasan, A., Al‐Ozairi, E., Albaqsumi, Z., Ahmad, R., & Al‐Mulla, F. (2021) · ImmunoTargets and Therapy · doi:10.2147/itt.s280706 · Cited by 56

Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients

Youngs, J., Provine, N. M., Lim, N. T. Y., Sharpe, H., Amini, A., Chen, Y., Luo, J. F., Edmans, M. D., Zacharopoulou, P., Chen, W., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009804 · Cited by 57

Interferon induction, evasion, and paradoxical roles during SARS‐CoV‐2 infection*

Chiale, C., Greene, T. T., & Zúñiga, E. I. (2022) · Immunological Reviews · doi:10.1111/imr.13113 · Cited by 66

Understanding COVID-19 in children: immune determinants and post-infection conditions

Rotulo, G. A., & Palma, P. (2023) · Pediatric Research · doi:10.1038/s41390-023-02549-7 · Cited by 60

T cell immune memory after covid-19 and vaccination

Wang, L., Nicols, A. R., Turtle, L. C. W., Richter, A. G., Duncan, C. J. A., Dunachie, S. J., Klenerman, P., & Payne, R. (2023) · BMJ Medicine · doi:10.1136/bmjmed-2022-000468 · Cited by 66

Ketogenic diet restrains aging-induced exacerbation of coronavirus infection in mice

Ryu, S., Shchukina, I., Youm, Y., Qing, H., Hilliard, B. K., Dlugos, T., Zhang, X., Yasumoto, Y., Booth, C. J., Fernandez-Hernando, C. F., et al. (2021) · eLife · doi:10.7554/elife.66522 · Cited by 65

COVID-19 in Children: Expressions of Type I/II/III Interferons, TRIM28, SETDB1, and Endogenous Retroviruses in Mild and Severe Cases

Tovo, P.-A., Garazzino, S., Daprà, V., Pruccoli, G., Calvi, C., Mignone, F., Alliaudi, C., Denina, M., Scolfaro, C., Zoppo, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147481 · Cited by 59

A regulatory T cell signature distinguishes the immune landscape of COVID-19 patients from those with other respiratory infections

Vick, S. C., Frutoso, M., Mair, F., Konecny, A., Greene, E., Wolf, C. R., Logue, J. K., Franko, N., Boonyaratanakornkit, J. B., Gottardo, R., et al. (2021) · Science Advances · doi:10.1126/sciadv.abj0274 · Cited by 58

B cell receptor repertoire kinetics after SARS-CoV-2 infection and vaccination

Kotagiri, P., Mescia, F., Rae, W. M., Bergamaschi, L., Tuong, Z. K., Turner, L., Hunter, K., Gerber, P. P., Hosmillo, M. D. T., Hess, C., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110393 · Cited by 61

T Cell Activation, Highly Armed Cytotoxic Cells and a Shift in Monocytes CD300 Receptors Expression Is Characteristic of Patients With Severe COVID-19

Zenarruzabeitia, O., Astarloa-Pando, G., Terrén, I., Orrantia, A., Pérez-Garay, R., Seijas, I., Arana, J. N., Imaz-Ayo, N., Pérez-Fernández, S., Arana‐Arri, E., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.655934 · Cited by 54

Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality

Brunet‐Ratnasingham, E., Anand, S. P., Gantner, P., Dyachenko, A., Moquin‐Beaudry, G., Brassard, N., Beaudoin-Bussières, G., Pagliuzza, A., Gasser, R., Benlarbi, M., et al. (2021) · Science Advances · doi:10.1126/sciadv.abj5629 · Cited by 54

Impact of ADAR-induced editing of minor viral RNA populations on replication and transmission of SARS-CoV-2

Ringlander, J., Fingal, J., Kann, H., Prakash, K., Rydell, G. E., Andersson, M., Martner, A., Lindh, M., Horal, P., Hellstrand, K., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2112663119 · Cited by 57

Comorbid illnesses are associated with altered adaptive immune responses to SARS-CoV-2

Yu, K. K. Q., Fischinger, S., Smith, M. T., Atyeo, C. G., Cizmeci, D., Wolf, C. R., Layton, E. D., Logue, J. K., Aguilar, M. S., Shuey, K. D., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.146242 · Cited by 56

The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study

Lomakin, N. V., Бакиров, Б. А., Николаевич, П. Д., Vi, M., Musaev, G., Моисеева, О. М., Pasechnik, E. S., Popov, V. V., Smolyarchuk, Е. А., Гордеев, И. Г., et al. (2021) · Inflammation Research · doi:10.1007/s00011-021-01507-5 · Cited by 58

Coronavirus Infection-Associated Cell Death Signaling and Potential Therapeutic Targets

Yapasert, R., Khaw-on, P., & Banjerdpongchai, R. (2021) · Molecules · doi:10.3390/molecules26247459 · Cited by 55

Neutrophil Extracellular Traps, Local IL-8 Expression, and Cytotoxic T-Lymphocyte Response in the Lungs of Patients With Fatal COVID-19

Melero, I., Villalba-Esparza, M., Zamacona, B. R., Jiménez‐Sánchez, D., Teijeira, Á., Argueta, A., García‐Tobar, L., Álvarez-Gigli, L., Sainz, C., García-Ros, D., et al. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.06.007 · Cited by 55

Genetic influences on viral-induced cytokine responses in the lung

Forbester, J. L., & Humphreys, I. R. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-00355-6 · Cited by 56

Gamma Delta T Cells and Their Involvement in COVID-19 Virus Infections

von Massow, G., Oh, S. K. W., Lam, A. T., & Gustafsson, K. T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.741218 · Cited by 55

Programmed cell death: the pathways to severe COVID-19?

Bader, S. M., Cooney, J. P., Pellegrini, M., & Doerflinger, M. (2022) · Biochemical Journal · doi:10.1042/bcj20210602 · Cited by 55

Cell Death in Coronavirus Infections: Uncovering Its Role during COVID-19

Paolini, A., Borella, R., Biasi, S. D., Neroni, A., Mattioli, M., Tartaro, D. L., Simonini, C., Franceschini, L., Cicco, G., Piparo, A. M., et al. (2021) · Cells · doi:10.3390/cells10071585 · Cited by 55

Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19

Feyaerts, D., Hedou, J. J., Gillard, J., Chen, H. M., Tsai, E. S., Peterson, L. S., Ando, K., Manohar, M., Do, E., Dhondalay, G. K., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100680 · Cited by 56

Longitudinal Analysis of COVID-19 Patients Shows Age-Associated T Cell Changes Independent of Ongoing Ill-Health

Townsend, L., Dyer, A. H., Naughton, A., Kiersey, R., Holden, D., Gardiner, M., Dowds, J., O’Brien, K., Bannan, C., Nadarajan, P., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.676932 · Cited by 58

Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19?

Hazeldine, J., & Lord, J. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.573662 · Cited by 55

Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test

Heggestad, J. T., Kinnamon, D., Olson, L. B., Liu, J., Kelly, G., Wall, S. A., Oshabaheebwa, S., Quinn, Z., Fontes, C. M., Joh, D. Y., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg4901 · Cited by 52

Severe COVID-19 Shares a Common Neutrophil Activation Signature with Other Acute Inflammatory States

Schimke, L. F., Marques, A. H. C., Baiocchi, G. C., Prado, C. A. D. S., Fonseca, D. L. M., Freire, P. P., Plaça, D. R., Filgueiras, I. S., Salgado, R. C., Jansen-Marques, G., et al. (2022) · Cells · doi:10.3390/cells11050847 · Cited by 50

mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include Omicron

Lee, H., Knabl, L., Moliva, J. I., Knabl, L., Werner, A. P., Boyoglu-Barnum, S., Kapferer, S., Pateter, B., Walter, M., Sullivan, N. J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110680 · Cited by 47

Protective neutralizing epitopes in SARS‐CoV‐2

Liu, H., & Wilson, I. A. (2022) · Immunological Reviews · doi:10.1111/imr.13084 · Cited by 49

SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections

Cyprian, F. S., Sohail, M. U., Abdelhafez, I., Salman, S., Attique, Z., Kamareddine, L., & Al‐Asmakh, M. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.02.071 · Cited by 50

Age-severity matched cytokine profiling reveals specific signatures in Covid-19 patients

Angioni, R., Sánchez‐Rodríguez, R., Munari, F., Bertoldi, N., Arcidiacono, D., Cavinato, S., Marturano, D., Zaramella, A., Realdon, S., Cattelan, A. M., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03151-z · Cited by 101

A systematic meta‐analysis of immune signatures in patients with COVID‐19

Liu, K., Yang, T., Peng, X., Lv, S., Ye, X., Zhao, T., Li, J., Shao, Z., Lu, Q., Li, J., et al. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2195 · Cited by 66

Longitudinal analyses reveal immunological misfiring in severe COVID-19

Lucas, C., Wong, P., Klein, J., Castro, T. B. R., Silva, J., Sundaram, M., Ellingson, M. K., Mao, T., Oh, J. E., Israelow, B., et al. (2020) · Nature · doi:10.1038/s41586-020-2588-y · Cited by 2,074

Multi-omic profiling reveals early immunological indicators for identifying COVID-19 Progressors

Drake, K., Talantov, D., Tong, G. J., Lin, J. T., Verheijden, S., Katz, S., Leung, J. M., Yuen, B., Krishna, V., Wu, M. J., et al. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109808 · Cited by 7

Characterisation of the pro-inflammatory cytokine signature in severe COVID-19

Hawerkamp, H. C., Dyer, A. H., Patil, N. D., McElheron, M., O’Dowd, N. A., O’Doherty, L., Mhaonaigh, A. U., George, A. M., O’Halloran, A. M., Reddy, C., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1170012 · Cited by 46